Back to Search Start Over

Zolpidem: A masked hero. A reply to ZORRO study.

Authors :
Lugoboni, Fabio
Casari, Rebecca
Fusina, Francesca
Zamboni, Lorenzo
Source :
British Journal of Clinical Pharmacology; Oct2021, Vol. 87 Issue 10, p4040-4041, 2p
Publication Year :
2021

Abstract

In their paper, Istvan and colleagues hint at the similarities between the regulation policies of flunitrazepam and zolpidem to draw conclusions about zolpidem's use. Indeed, of the about 1400 cases of hospitalization for addiction to high doses of benzodiazepines and the like in our institution, none were due to flunitrazepam, while more than half of them were due to lormetazepam. Https://doi.org/10.1007/s11739-020-02538-2 5 Lugoboni F, Bertoldi A, Casari R, Mantovani E, Morbioli L, Tamburin S. Adult attention-deficit/hyperactivity disorder and quality of life in high-dose benzodiazepine and related Z-drug users. [Extracted from the article]

Details

Language :
English
ISSN :
03065251
Volume :
87
Issue :
10
Database :
Complementary Index
Journal :
British Journal of Clinical Pharmacology
Publication Type :
Academic Journal
Accession number :
152602273
Full Text :
https://doi.org/10.1111/bcp.14820